Board Name | Posts By frankbell1964 | Post Created |
---|---|---|
DECN Decision Diagnostics Corp | 100 Genultimate Count http://www.ph | 02/23/2017 5:46:19 PM |
DECN Decision Diagnostics Corp | http://minishop.gmarket.co.kr/kjca ![]() | 02/22/2017 5:53:15 PM |
DECN Decision Diagnostics Corp | Commercial is fine, I was more focu ![]() | 02/20/2017 8:08:29 PM |
DECN Decision Diagnostics Corp | Please review the current commercia ![]() | 02/20/2017 11:20:43 AM |
DECN Decision Diagnostics Corp | Which of the big 4 is GenSure creat ![]() | 02/19/2017 1:19:21 PM |
DECN Decision Diagnostics Corp | Be very careful you don't bring ove ![]() | 02/18/2017 9:34:06 AM |
DECN Decision Diagnostics Corp | First purchase today between .07-.0 ![]() | 02/17/2017 5:49:11 PM |
DECN Decision Diagnostics Corp | I abstain from participating in suc ![]() | 02/17/2017 8:13:29 AM |
DECN Decision Diagnostics Corp | Chemist823-IMO, After doing some re ![]() | 02/16/2017 5:26:55 PM |
Recent Articles
- Iceland's Stable Credit Ratings and Economic Outlook Explained
- Welsbach Technology Metals and Evolution Metals Combine Forces
- Steakholder Foods to Implement Major ADS Split Adjustment
- Children’s Place: Resilient Performance Amid Challenges
- Welsbach Technology Metals: New Chapter with Evolution Metals
- DIH Holding US, Inc. Faces Nasdaq Compliance Challenges Ahead
- Portillo's Welcomes Denise Lauer as New CMO to Drive Growth
- Sonoro Gold Corp Expands Private Placement Amid Investor Interest
- Key Insights on Nyxoah's Transparency Notifications Shift
- Integral Metals Extends Marketing Services Collaboration
- Portillo’s Welcomes Denise Lauer as New Chief Marketing Officer
- DBV Technologies Unveils New ATM Program for Investor Funding
- DBV Technologies Launches New At-The-Market Program on Nasdaq
- Nyxoah SA Reports Significant Transparency Update Announcement
- American Healthcare REIT's Key Conference Participation and Goals
- A Comprehensive Look at Qualys Short Sales and Market Sentiment
- Understanding Recent Trends in SBA Communications' Short Interest
- Understanding SuperCom’s Short Interest Trends and Insights
- How Investing in Norfolk Southern Can Change Your Future Wealth
- Exploring the ZYN ETF: A Strategic Investment in Tobacco
- Children's Place Sees Shift in Sales Amid New Initiatives
- Tronox Holdings PLC Faces Investor Scrutiny Over Stock Decline
- Blue Water Acquisition Corp. III Makes $10 Billion Bid to Acquire Citgo
- PINTEC Partners with ZIITECH: Strategic Share Exchange
- Lipocine Announces Key Presentation at Global Investment Conference
- Shapellx's Dual Triumph at Muse Design Awards Reinforces Dominance
- Crown Castle CFO to Present at Key Investment Conference
- Old National Bancorp's Participation in Upcoming Finance Conference
- Exploring Growth: The Rise of Popular Inc. Stock Value
- Tronox Holdings Faces Investigation Amid Investor Concerns
- Understanding the Decline in Charles Schwab's Share Price
- Exciting Offers for the RAM 1500 at Chris Auffenberg Dealerships
- Innovative Apprenticeship Program by Syntec Optics for Future Leaders
- Concerns Rise Over Carbon Pipeline Bills and Lobbyist Influence
- Tampa General Hospital Achieves Prestigious FACT Accreditation
- Southwest Gas Transitions to Full Regulatory Focus After Centuri Sale
- Investors in Lineage, Inc. Can Join Class Action Lawsuit Now
- Upcoming Earnings Call Highlights for Vail Resorts, Inc.
- Artivion to Show Innovations at Esteemed Healthcare Conference
- Arthur J. Gallagher & Co. Announces Upcoming Investor Meeting
- Explore American Healthcare REIT's Upcoming Conference Insights
- ProCure Proton Therapy Center Advocates for Prostate Cancer Care
- Wing It On! Achieves Remarkable Success at National Wing Fest
- Trends in Used Aircraft Prices: Jets Down, Piston Singles Steady
- Engaging Moments Ahead: Gyre Therapeutics at Major Conference
- Innovative Apprenticeship Program Launches at Syntec Optics
- Old National Bancorp Set to Shine at Barclays Financial Event
- Crown Castle Engages Stakeholders at RBC Capital Markets Event
- Arcutis Biotherapeutics Expands Team with New Inducement Grants
- Purple Biotech Secures $18 Million Offering for Oncology Advancements